Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408 Study Data

BACKGROUND: No gold-standard patient-reported outcome measure of chemotherapy-induced peripheral neuropathy (CIPN) exists. OBJECTIVE: To re-evaluate the sensitivity, reliability, and validity of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Nurs
Autores principales: Lavoie Smith, Ellen M., Banerjee, Tanima, Yang, James J., Bridges, Celia M., Alberti, Paola, Sloan, Jeff A., Loprinzi, Charles
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6185825/
https://ncbi.nlm.nih.gov/pubmed/29649081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/NCC.0000000000000596
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares